Wegovy coverage and savings program information (eligibility, caps, and terms)
Obese weight management
The goal is to identify individuals for whom GLP-1 therapy is clinically appropriate and likely to support sustainable outcomes when administered under supervision
While Semaglutide GLP-1 is generally well-tolerated by most patients, it does have potential side effects, including nausea, vomiting, abdominal pain, and diarrhea
Frequently Asked Questions About Compounded Semaglutide What is the difference between compounded semaglutide and brand-name options
Two retrospective database studies have also evaluated weight outcomes with tirzepatide in patients without T2DM, with reported weight loss of 11.9% and 12.9% after 6 months of follow-up [13, 14]